Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 24458185)

1.

Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.

Ahmadzadehfar H, Pieper CC, Ezziddin S, Biersack HJ, Meyer C.

Clin Nucl Med. 2014 Mar;39(3):305-7. doi: 10.1097/RLU.0000000000000367.

PMID:
24458185
2.

A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS.

J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007.

PMID:
24461133
3.

SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.

Hamami ME, Poeppel TD, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G.

J Nucl Med. 2009 May;50(5):688-92. doi: 10.2967/jnumed.108.058347. Epub 2009 Apr 16.

4.

Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.

Padia SA, Alessio A, Kwan SW, Lewis DH, Vaidya S, Minoshima S.

J Vasc Interv Radiol. 2013 Aug;24(8):1147-53. doi: 10.1016/j.jvir.2013.04.018. Epub 2013 Jun 20.

PMID:
23792126
5.

Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.

Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E.

J Nucl Med. 2012 Feb;53(2):255-63. doi: 10.2967/jnumed.111.094235.

6.

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG.

J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7.

7.

Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.

Bilbao JI, Garrastachu P, Herráiz MJ, Rodríguez M, Iñarrairaegui M, Rodríguez J, Hernández C, de la Cuesta AM, Arbizu J, Sangro B.

Cardiovasc Intervent Radiol. 2010 Jun;33(3):523-31. doi: 10.1007/s00270-009-9717-1. Epub 2009 Oct 20.

PMID:
19841973
8.

Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.

Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, Tay KH, Tan BS, Hoe Chow PK, Eng Ng DC, Whatt Goh AS.

J Nucl Med. 2012 Apr;53(4):559-66. doi: 10.2967/jnumed.111.097469. Epub 2012 Feb 17.

9.

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.

Iñarrairaegui M, Thurston KG, Bilbao JI, D'Avola D, Rodriguez M, Arbizu J, Martinez-Cuesta A, Sangro B.

J Vasc Interv Radiol. 2010 Aug;21(8):1205-12. doi: 10.1016/j.jvir.2010.04.012. Epub 2010 Jul 3.

PMID:
20598574
10.

Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.

Meyer C, Pieper CC, Ezziddin S, Wilhelm KE, Schild HH, Ahmadzadehfar H.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):231-7. doi: 10.1007/s00259-013-2550-4. Epub 2013 Sep 13.

PMID:
24030669
11.

99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization.

Ahmadzadehfar H, Sabet A, Muckle M, Wilhelm K, Reichmann K, Biersack HJ, Ezziddin S.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1281-8. doi: 10.1007/s00259-011-1751-y. Epub 2011 Feb 26.

PMID:
21359611
12.

Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.

Lam MG, Goris ML, Iagaru AH, Mittra ES, Louie JD, Sze DY.

J Nucl Med. 2013 Dec;54(12):2055-61. doi: 10.2967/jnumed.113.123257. Epub 2013 Oct 21.

13.

Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?

Burgmans MC, Too CW, Kao YH, Goh AS, Chow PK, Tan BS, Tay KH, Lo RH.

Eur J Radiol. 2012 Dec;81(12):3979-84. doi: 10.1016/j.ejrad.2012.08.007. Epub 2012 Sep 3.

PMID:
22954411
14.

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.

Garin E, Rolland Y, Boucher E, Ardisson V, Laffont S, Boudjema K, Bourguet P, Raoul JL.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):453-61. doi: 10.1007/s00259-009-1279-6. Epub 2009 Oct 10.

PMID:
19820932
15.

The role of SPECT/CT in radioembolization of liver tumours.

Ahmadzadehfar H, Duan H, Haug AR, Walrand S, Hoffmann M.

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S115-24. doi: 10.1007/s00259-013-2675-5. Epub 2014 Jan 18. Review.

PMID:
24442600
16.

Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.

Burgmans MC, Kao YH, Irani FG, Dames EL, Teo TK, Goh AS, Chow PK, Tay KH, Lo RH.

J Vasc Interv Radiol. 2012 Oct;23(10):1294-301. doi: 10.1016/j.jvir.2012.07.009. Epub 2012 Aug 24.

PMID:
22922039
17.

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.

Garin E, Lenoir L, Edeline J, Laffont S, Mesbah H, Porée P, Sulpice L, Boudjema K, Mesbah M, Guillygomarc'h A, Quehen E, Pracht M, Raoul JL, Clement B, Rolland Y, Boucher E.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1057-68. doi: 10.1007/s00259-013-2395-x. Epub 2013 Apr 24.

18.

Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.

Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S; European Network on Radioembolization with Yttrium-90 Microspheres (ENRY) study collaborators.

J Hepatol. 2013 Oct;59(4):753-61. doi: 10.1016/j.jhep.2013.05.025. Epub 2013 May 23.

PMID:
23707371
19.
20.

Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.

Ulrich G, Dudeck O, Furth C, Ruf J, Grosser OS, Adolf D, Stiebler M, Ricke J, Amthauer H.

J Nucl Med. 2013 Apr;54(4):516-22. doi: 10.2967/jnumed.112.112508. Epub 2013 Feb 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk